• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

轮椅干预措施的经济评价:系统评价。

Economic evaluation of wheelchairs interventions: a systematic review.

机构信息

Departamento de Ciências do Movimento Humano, Universidade Federal de São Paulo, Santos, Brazil.

Departamento de Medicina Preventiva, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.

出版信息

Disabil Rehabil Assist Technol. 2023 Oct;18(7):1163-1174. doi: 10.1080/17483107.2021.1993360. Epub 2021 Nov 9.

DOI:10.1080/17483107.2021.1993360
PMID:34753399
Abstract

OBJECTIVE

The overall aim of this systematic review was to identify and synthesise the best available evidence on effectiveness, resource use and costs involved in wheelchair interventions of adults with mobility limitations.

METHODOLOGY

This systematic review was undertaken in accordance with the Centre for Reviews and Dissemination Guidelines. The protocol for this systematic review was registered with PROSPERO International Prospective Register of Systematic reviews. The following PICOS eligibility criteria were considered: (P) Population was individuals with mobility limitations that live in their community (e.g., non-institutionalized), with aged 18 or older; (I) Intervention was mobility assistive technologies (MAT), such as manual and powered wheelchairs; (C) Comparators (Not Applied); (O) Outcome, the primary outcome of interest, was established as the cost-effectiveness of wheelchair interventions. Direct and indirect costs per unit of effect were expressed in terms of clinical outcome units, quality-adjusted life years gained, utility scores, quality of life measures and incremental cost-effectiveness ratios to inform the economic outcomes. (S) Study design was considered as a health economic evaluation (i.e., including cost-effectiveness analysis, cost-utility analysis and cost benefit analysis as well as partial economic evaluations). The Consolidated Health Economic Evaluation Reporting Standards - CHEERS, checklist was used for summarising and interpreting the results of economic evaluations.

RESULTS

Sixteen studies were included, two were identified as full health economic evaluations and 14 were considered partial health economic evaluations.

CONCLUSION

Only two full health economic analyses of wheelchair interventions have been conducted and both focussed on powered wheelchair provision. There are important gaps in current knowledge regarding wheelchair health economic methods and available outcome measures, which there is a great need for further research.Implication for RehabilitationSystematic reviews of health economic evaluation studies are useful for synthesising economic evidence about health interventions and provide insight in new research development.Organisations involved in the provision of wheelchairs should apply cost-effectiveness outcome measures to help raise the standard of provision, to support evidence-based practice, and to improve resource utilisation.

摘要

目的

本系统评价的总体目标是确定和综合有关成人移动障碍者轮椅干预措施的有效性、资源利用和成本的最佳现有证据。

方法

本系统评价是根据考科蓝中心的指南进行的。本系统评价的方案已在 PROSPERO 国际前瞻性系统评价注册库中注册。考虑了以下 PICOS 纳入标准:(P)人群为居住在社区(例如非机构化)的有移动障碍的个体,年龄在 18 岁或以上;(I)干预措施为移动辅助技术(MAT),如手动和动力轮椅;(C)对照(不适用);(O)结局,主要关注的结局是轮椅干预措施的成本效益。每单位效果的直接和间接成本以临床结局单位、获得的质量调整生命年、效用评分、生活质量衡量标准和增量成本效益比表示,以告知经济结果。(S)研究设计被认为是健康经济评估(即包括成本效益分析、成本效用分析和成本效益分析以及部分经济评估)。使用统一的健康经济评估报告标准 - CHEERS 清单总结和解释经济评估的结果。

结果

纳入了 16 项研究,其中 2 项被确定为完整的健康经济评估,14 项被认为是部分健康经济评估。

结论

只有两项关于轮椅干预措施的全健康经济分析,并且都集中在动力轮椅的供应上。关于轮椅健康经济方法和现有结果衡量标准的现有知识存在重要差距,因此非常需要进一步研究。

康复的意义

健康经济评价研究的系统评价对于综合有关健康干预措施的经济证据非常有用,并为新的研究进展提供了深入的了解。

参与轮椅提供的组织应应用成本效益结果衡量标准,以帮助提高提供标准,支持基于证据的实践,并改善资源利用。

相似文献

1
Economic evaluation of wheelchairs interventions: a systematic review.轮椅干预措施的经济评价:系统评价。
Disabil Rehabil Assist Technol. 2023 Oct;18(7):1163-1174. doi: 10.1080/17483107.2021.1993360. Epub 2021 Nov 9.
2
Powered mobility interventions for very young children with mobility limitations to aid participation and positive development: the EMPoWER evidence synthesis.助力行动能力受限的非常年幼儿童参与和积极发展的电动移动干预措施:EMPOWER 证据综合研究。
Health Technol Assess. 2020 Oct;24(50):1-194. doi: 10.3310/hta24500.
3
Conceptual mapping proposed to comprehend the effect of wheelchair mobility on social participation and quality of life: a systematic review.为理解轮椅移动性对社会参与和生活质量的影响而提出的概念性映射:一项系统综述。
Disabil Rehabil Assist Technol. 2024 Apr;19(3):814-830. doi: 10.1080/17483107.2022.2126904. Epub 2022 Oct 19.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Systematic Review of Economic Evaluations of Systemic Treatments for Advanced and Metastatic Gastric Cancer.晚期和转移性胃癌全身治疗的经济学评价系统评价
Pharmacoeconomics. 2024 Oct;42(10):1091-1110. doi: 10.1007/s40273-024-01413-8. Epub 2024 Jul 26.
6
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
7
Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.行为修正干预对初级保健中无法用医学解释的症状:系统评价和经济评估。
Health Technol Assess. 2020 Sep;24(46):1-490. doi: 10.3310/hta24460.
8
The clinical effectiveness and cost-effectiveness of home-based, nurse-led health promotion for older people: a systematic review.基于家庭的、由护士主导的老年人健康促进的临床效果和成本效益:系统评价。
Health Technol Assess. 2012;16(20):1-72. doi: 10.3310/hta16200.
9
Prophylactic removal of impacted mandibular third molars: a systematic review and economic evaluation.预防性拔除下颌阻生第三磨牙:系统评价和经济评估。
Health Technol Assess. 2020 Jun;24(30):1-116. doi: 10.3310/hta24300.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.